The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 06, 2024

Filed:

May. 24, 2018
Applicant:

Chugai Seiyaku Kabushiki Kaisha, Tokyo, JP;

Inventors:

Tomoyuki Igawa, Shizuoka, JP;

Shinya Ishii, Shizuoka, JP;

Miho Funaki, Shizuoka, JP;

Naoka Hironiwa, Shizuoka, JP;

Atsuhiko Maeda, Shizuoka, JP;

Junichi Nezu, Shizuoka, JP;

Yoshinao Ruike, Shizuoka, JP;

Takeshi Baba, Shizuoka, JP;

Shun Shimizu, Shizuoka, JP;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/18 (2006.01); C07K 16/24 (2006.01); C07K 16/28 (2006.01); C07K 16/42 (2006.01); G01N 33/53 (2006.01);
U.S. Cl.
CPC ...
C07K 16/18 (2013.01); C07K 16/248 (2013.01); C07K 16/2866 (2013.01); C07K 16/4291 (2013.01); G01N 33/53 (2013.01); C07K 2317/565 (2013.01);
Abstract

An objective of the present invention is to provide methods for promoting antigen uptake into cells by antigen-binding molecules, methods for increasing the number of times of antigen binding by one antigen-binding molecule, methods for promoting reduction of the antigen concentration in plasma by administering antigen-binding molecules, and methods for improving the plasma retention of an antigen-binding molecule, as well as antigen-binding molecules that allow enhanced antigen uptake into cells, antigen-binding molecules having an increased number of times of antigen binding, antigen-binding molecules that can promote reduction of the antigen concentration in plasma when administered, antigen-binding molecules with improved plasma retention, pharmaceutical compositions comprising the above antigen-binding molecules, and methods for producing them. The present inventors revealed that the above objective can be achieved by using antigen-binding molecules that show calcium-dependent antigen-antibody reaction.


Find Patent Forward Citations

Loading…